3P Bio will focus on the transfer of the production process as well as the cGMP manufacturing of the drug substance to be used in Phase I and II clinical trials. The novel drug could cure neurodegene...
The researchers attribute the loss of motor neurons in patients with Amyotrophic Lateral Sclerosis (ALS) to a new mechanism that blocks any cellular reaction that involves nucleic acids (DNA or RNA...
Researchers from IBEC and CRG in Barcelona use a technique called high-throughput mutagenesis to study Amyotrophic Lateral Sclerosis (ALS), with unexpected results.
The researchers analyzed energy production spinal cord cells in vitro and in mice. Mitochondria of neurons, some organelles that provide energy to the cells begin to malfunction before ALS manifests i...
El hecho de que existan pacientes con más de una mutación patológica tiene repercusiones importantes a la hora de diagnosticar a los pacientes y sobre todo para calcular los riesgos de transmisión...